APA

Rigby W., Tony H., Oelke K., Combe B., Laster A., von Muhlen C. A., Fisheleva E., Martin C., Travers H. & Dummer W. (20120913). Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trial. : Arthritis and rheumatism.

Chicago

Rigby W, Tony H-P, Oelke K, Combe B, Laster A, von Muhlen C A, Fisheleva E, Martin C, Travers H and Dummer W. 20120913. Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trial. : Arthritis and rheumatism.

Harvard

Rigby W., Tony H., Oelke K., Combe B., Laster A., von Muhlen C. A., Fisheleva E., Martin C., Travers H. and Dummer W. (20120913). Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trial. : Arthritis and rheumatism.

MLA

Rigby W, Tony H-P, Oelke K, Combe B, Laster A, von Muhlen C A, Fisheleva E, Martin C, Travers H and Dummer W. Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trial. : Arthritis and rheumatism. 20120913.